medigraphic.com
ISSN 1405-8871 (Print)

2023, Number 2

<< Back Next >>

Aten Fam 2023; 30 (2)

Sarcopenia and its connection with geriatric dysfunctionality in a family medicine unit

Valencia-Reyes JM, Vega-Blancas JL

Language: Spanish
References: 19
Page: 120-126
PDF size: 151.30 Kb.


ABSTRACT

Objective: to identify the prevalence of sarcopenia and its connection with geriatric dysfunction in a family medicine unit. Methods: descriptive study; 174 patients over 65 years of age of both sexes were included. Non-probabilistic convenience non-probabilistic sampling. The SARC-F questionnaire was used for screening, the EWGSOP2 algorithm to determine the presence and degree of sarcopenia and the Katz test to assess the degree of functional dependence with basic activities of daily living. Statistical analysis was carried out using the SPSS v program. 22. To relate the presence and degree of sarcopenia with functional dependence, the χ2 test was used with a significance level of 0.05 and Spearman’s Rho was used. Results: it was observed that women have a higher prevalence of sarcopenia, the highest age was 80 years and older. The variables with association were presence and degree of sarcopenia with the degree of functional dependence, Spearman’s Rho 0.491 and 0.411, respectively; with statistical significance (p‹0.000). Conclusion: age and female sex influence the development of sarcopenia. The prevalence of the latter, and the dependence on basic activities of daily living, will depend on the biological and social factors of each individual; because of this, it is necessary to carry out an exhaustive search for cases with risk factors in order to have a timely impact on these patients and avoid complications.


REFERENCES

  1. OMS. Envejecimiento y salud [Internet]. [Citado 2022 may 23]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/ageing-andhealth

  2. Instituto Nacional de Estadística y Geografía. Estadísticasa propósito del día internacional de las personasde edad [Internet]. [Citado 2022 may 23].Disponible en https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2018/edad2018_nal.pdf

  3. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, LarijaniB, Heshmat. Prevalence of sarcopenia in the world:A systematic review and meta- analysis of generalpopulation studies. J Diabetes Metab Disord.2017;16:21. DOI: 10.1186/s40200-017-0302-x

  4. Kim M, Won CW. Prevalence of sarcopenia incommunity-dwelling older adults using the definitionof the European Working Group on Sarcopeniain Older People 2: Findings from the KoreanFrailty and Aging Cohort Study. Age Ageing.2019;48(6):910-6. DOI: 10.1093/ageing/afz091

  5. Anker SD, Morley JE, Von Haehling S. Welcometo the ICD-10 code for sarcopenia. J Cachexia SarcopeniaMuscle. 2016;7(5):512-4. DOI: 10.1002/jcsm.12147

  6. Cruz AJ, Bahat G, Bauer J, Boirie Y, Bruyere O,Cederholm T, et al. Sarcopenia: Revised Europeanconsensus on definition and diagnosis. Age Ageing.2019;48(1):16-31. DOI: 10.1093/ageing/afy169

  7. Morley JE. Treatment of sarcopenia: the roadto the future. J Cachexia Sarcopenia Muscle.2018;9(7):1196-1199. DOI: 10.1002/jcsm.12386

  8. Dhillon RJ, Hasni S. Pathogenesis and Managementof Sarcopenia. Clin Geriatr Med 2017;33(1):17-26. DOI: 10.1016/j.cger.2016.08.002

  9. Dao T, Green AE, Kim YA, Bae SJ, Ha KT, GarianiK, et al. Sarcopenia and Muscle Aging: A BriefOverview. Endocrinol Metab 2020;35(4):716-732. DOI: 10.3803/EnM.2020.405

  10. Espinel-Bermúdez MC, Sánchez-García S, García-Peña C, Trujillo X, Huerta-Vieyra M, Granados-García V, et al. Factores asociados a sarcopenia enadultos mayores mexicanos: Encuesta Nacional deSalud y Nutrición 2012. Rev Med Inst Mex SeguroSoc. 2018;56(Supl-1):S46-53.

  11. Wackerhage H. Sarcopenia: Causes and treatments.Dtsch Z Sportmed. 2017;68:178-84. DOI:10.5960/dzsm.2017.289

  12. Chew S. Sarcopenia: causes, consequences, prevention,and treatment. Singapore Fam Physician2018;44(5):11-17. DOI: 10.33591/sfp.44.5.u2

  13. Morley JE. Treatment of sarcopenia: the roadto the future. J Cachexia Sarcopenia Muscle.2018;9(7):1196-1199. DOI: 10.1002/jcsm.12386

  14. Lara MA, Limón NA, Cortes DB, Nuncio JL,Cortez LC. Funcionalidad y Pérdida de masamuscular en el adulto mayor. Rev Med Electrón.2019;14(23):547-555.

  15. Nishikawa H, Fukunishi S, Asai A, YokohamaK, Nishiguchi S, Higuchi K. Pathophysiologyand mechanisms of primary sarcopenia (Review).Int J Mol Med. 2021;48(2):156. DOI: 10.3892/ijmm.2021.4989

  16. Tournadre A, Vial G, Capel F, Soubrier M, BoirieY. Sarcopenia. Joint Bone Spine. 2019;86(3):309-314. DOI: 10.1016/j.jbspin.2018.08.001

  17. Sieber CC. Malnutrition and sarcopenia. AgingClin Exp Res. 2019;31(6):793-798. DOI:10.1007/s40520-019-01170-1

  18. Distefano G, Goodpaster BH. Effects of Exerciseand Aging on Skeletal Muscle. Cold SpringHarb Perspect Med. 2018;8(3):a029785. DOI:10.1101/cshperspect.a029785.

  19. Envejecimiento y discapacidad: implicaciones económicaspara los hogares en México. Foro Envejecimientoy Salud: Investigación para un plan de acción[Internet]. [Citado 2022 may 23] Disponibleen: http://www.geriatria.salud.gob.mx/descargas/publicaciones/foro-envejecimiento/FS_ENVEJECIMIENTO_DISCAPACIDAD.pdf




2020     |     www.medigraphic.com